Answers are grounded in this paper and cite their sources.
This randomized trial investigates renal dysfunction caused by chemotherapy in children, indicating a need for careful monitoring.
The clinical use of antineoplastic drugs can be limited by different drug-induced toxicities. Of these, renal dysfunction may be one of the most troublesome in that it can be cumulative and in general is only partially reversible with the discontinuation of the treatment. Renal toxicity may be manifested as a reduction of the glomerular filtration rate, electrolyte imbalances, or acute renal failure. Careful assessment of renal function has to be performed taking into account that the impairment of renal function is initially silent and only later may be clinically dramatic. When clinically indicated, the reduction or, in cases of severe nephrotoxicity, the suspension of chemotherapy should be considered to avoid the progressive deterioration of the compromised glomerular and/or tubular function.
No takes yet. Share an insight, caveat, or question.
Ruggiero et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: